NASDAQ:BEATW HeartBeam (BEATW) Stock Price, News & Analysis $0.07 -0.01 (-14.61%) As of 05/22/2026 02:23 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock About HeartBeam Stock (NASDAQ:BEATW) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get HeartBeam alerts:Sign Up Key Stats Today's Range$0.05▼$0.1050-Day Range$0.07▼$0.1552-Week Range$0.05▼$0.78Volume33,483 shsAverage Volume5,028 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview HeartBeam, Inc. is a clinical-stage medical technology company focused on transforming the diagnosis of acute cardiac events through innovative electrocardiogram (ECG) solutions. The company’s core offering leverages proprietary VectorBEAM™ technology to reconstruct a full 12-lead ECG from a compact, three-lead wearable or handheld device. By enabling rapid acquisition and secure transmission of high-fidelity ECG data, HeartBeam’s approach aims to expedite the detection of myocardial ischemia in out-of-hospital settings. HeartBeam’s product ecosystem combines hardware, mobile applications, and cloud-based analytics. The wearable or handheld form factor is designed for use by patients, first responders, and telehealth providers, facilitating real-time triage and remote consultation with cardiovascular specialists. The accompanying software platform supports automated comparisons of current readings against patient-specific baseline ECGs, enhancing the accuracy of ischemia detection and reducing reliance on subjective interpretation. Based in Santa Monica, California, HeartBeam is conducting clinical studies to validate its technology in collaboration with leading medical centers and emergency medical services organizations across the United States. The company’s regulatory strategy has included submissions to the U.S. Food and Drug Administration and engagements with European health authorities in anticipation of broader market access. HeartBeam’s leadership team combines experience in medical device development, cardiovascular clinical research, and digital health commercialization, positioning the company to address critical gaps in early heart attack diagnosis and remote patient monitoring.AI Generated. May Contain Errors. Read More Receive BEATW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HeartBeam and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BEATW Stock News HeadlinesHeartBeam Appoints CEO Robert Eno to BoardMay 5, 2025 | tipranks.comHeartBeam’s Earnings Call Highlights Strategic ProgressMarch 14, 2025 | tipranks.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.May 25 at 1:00 AM | Banyan Hill Publishing (Ad)For Raiders' Hated AFC West Rival, Heartbreak Never EndsNovember 11, 2024 | msn.comHeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | msn.comBo Watch: Denver rookie QB holds his own against Super Bowl champs … only to lose in heartbreakNovember 10, 2024 | msn.comHeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA SubmissionsNovember 9, 2024 | theglobeandmail.comRob Sheffield's new book on Taylor Swift an emotional jaunt through a layered careerNovember 8, 2024 | usatoday.comSee More Headlines BEATW Stock Analysis - Frequently Asked Questions How have BEATW shares performed this year? HeartBeam's stock was trading at $0.32 at the beginning of 2026. Since then, BEATW shares have decreased by 77.5% and is now trading at $0.0719. How do I buy shares of HeartBeam? Shares of BEATW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/25/2026Next Earnings (Estimated)8/06/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (11m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 BEATW's financial health is in the Yellow zone, according to TradeSmith. BEATW has been in this zone for over 11 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health Information Services Sub-IndustryMedical Equipment Current SymbolNASDAQ:BEATW CIK1779372 Webwww.heartbeam.com Phone408-899-4443FaxN/AEmployees5Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:BEATW) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartBeam, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartBeam With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.